Contakt

Jorda Radek

E-mail: radek.jorda@upol.cz

Publications (Impact Factor Journals)

  • [9]
    JORDA, R., P. MAGAR, D. HENDRYCHOVA, K. PAUK, M. DIBUS, E. PILAROVA, A. IMRAMOVSKY a V. KRYŠTOF. Novel modified leucine and phenylalanine dipeptides modulate viability and attachment of cancer cells. European Journal of Medicinal Chemistry. 2020, 188, 112036. ISSN 0223-5234. IF: 4.833. PMID: 31931341
  • [8]
    SALAS C., O., A. ZARATE, V. KRYŠTOF, J. MELLA, M. FAUNDEZ, J. BREA, M. LOZA, I. BRITO, D. HENDRYCHOVA, R. JORDA, A. CABRERA, R. TAPIA a C. ESPINOSA-BUSTOS. Promising 2,6,9-Trisubstituted Purine Derivatives for Anticancer Compounds: Synthesis, 3D-QSAR, and Preliminary Biological Assays. International Journal of Molecular Sciences. 2020, 21(1), pii: E161. ISSN 1422-0067. IF: 4.183. PMID: 31881717
  • [7]
    BERTRAND, J., H. DOSTÁLOVÁ, V. KRYŠTOF, R. JORDA, A. CASTRO, J. MELLA, C. ESPINOSA-BUSTOS, A. ZARATE a O. SALAS C.. nema afiliaci ÚMTM_New 2,6,9-trisubstituted purine derivatives as Bcr-Abl and Btk inhibitors and as promising agents against leukemia. Bioorganic Chemistry. 2020, -, -. ISSN 0045-2068. IF: 3.926. PMID: 31699386
  • [6]
    KRAJČOVIČOVÁ, S., R. JORDA, D. HENDRYCHOVA, V. KRYŠTOF a M. SOURAL. Solid-phase synthesis for thalidomide-based proteolysis-targeting chimeras (PROTAC). Chemical Communications. 2019, 55(7), -. ISSN 929-932. IF: 6.290. PMID: 30601480
  • [5]
    JORDA, R., Z. BUCKOVA, E. ŘEZNÍČKOVÁ, J. BOUCHAL a V. KRYŠTOF. Selective inhibition reveals cyclin-dependent kinase 2 as another kinase that phosphorylates the androgen receptor at serine 81. Biochimica et Biophysica Acta. 2018, 1865(2), 354-363. ISSN 0006-3002. IF: 4.521. PMID: 29157894
  • [4]
    VANDA, D., R. JORDA, B. LEMROVÁ, T. VOLNÁ, V. KRYŠTOF, C. MCMASTER a M. SOURAL. Synthesis of Novel N9‑Substituted Purine Derivatives from Polymer Supported α‑Amino Acids. ACS Combinatorial Science. 2015, 17(7), 426-432. ISSN 2156-8952. IF: 3.317. PMID: 26098936
  • [3]
    ŘEZNÍČKOVÁ, E., A. POPA, T. GUCKÝ, M. ZATLOUKAL, L. HAVLICEK, V. BAZGIER, K. BERKA, R. JORDA, I. POPA, A. NASEREDDIN, C. JAFFE, V. KRYŠTOF a M. STRNAD. 2,6,9-Trisubstituted purines as CRK3 kinase inhibitors with antileishmanial activity in vitro. Bioorganic and Medicinal Chemistry Letters. 2015, 25(11), 2298-2301. ISSN 0960-894X. IF: 2.486. PMID: 25937014
  • [2]
    JORDA, R., L. HAVLICEK, I.W. MCNAE, M.D. WALKINSHAW, J. VOLLER, A. STURC, J. NAVRATILOVA, M. KUZMA, M. MISTRÍK, J. BÁRTEK, M. STRNAD a V. KRYŠTOF. Pyrazolo[4,3-d]pyrimidine Bioisostere of Roscovitine: Evaluation of a Novel Selective Inhibitor of Cyclin-Dependent Kinases with Antiproliferative Activity. Journal of Medicinal Chemistry. 2011, 54(8), 2980-2993. ISSN 0022-2623. IF: 5.248. PMID: 21417417
  • [1]
    PAPRSKÁŘOVÁ, M., V. KRYŠTOF, R. JORDA, P. DŽUBÁK, M. HAJDÚCH, J. WESIERSKA-GADEK a M. STRNAD. Functional p53 in cells contributes to the anticancer effect of the cyclin-dependent kinase inhibitor roscovitine. Journal of Cellular Biochemistry. 2009, 107(3), 428-437. ISSN 0730-2312. IF: 1.330. PMID: 19308936